Se connecter S'abonner en ligne
  • Infos sociétés
  • Infos OPCVM
  • Alertes e-mail
  • Notre offre
 Langues  Par thème  Par secteur d'activité  Par pays
G.ST Antivirals GmbH    
[09/04/2024]

G.ST Antivirals GmbH : EQS-News: G.ST Antivirals reports start of Phase II trial and announces appointment of Ronald Bruce Turner as new Chief Medical Officer

EQSNews: G.ST Antivirals GmbH / Key words: Personnel/Research Update G.ST Antivirals reports start of Phase II trial and announces appointment of Ronald Bruce Turner as new Chief Medical Officer 09.04.2024 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. G.... Lire le communiqué
 
G.ST Antivirals GmbH    
[25/01/2024]

G.ST Antivirals GmbH : EQS-News: G.ST Antivirals reports positive Phase I trial results for 2-Deoxy-D-glucose against upper respiratory infections

EQSNews: G.ST Antivirals GmbH / Key words: Study results/Financing G.ST Antivirals reports positive Phase I trial results for 2DeoxyDglucose against upper respiratory infections 25.01.2024 / 09:30 CET/CEST The issuer is solely responsible for the content of this announcement. G.ST Antivirals r... Lire le communiqué
 


Vidéos
Gestionnaires,
Emetteurs,
Ma sélection
Les communiqués les plus lus de G.ST An...